MODERNA (MRNA)
$32.81
0.15 (0.46%)
MRNA Stock Quote Delayed 30 Minutes
3 Biotech Stocks Poised for a Comeback After Last Week’s Market Meltdown
Investors should closely watch these three biotech stocks as their strong prospects are likely to help the rebound from market volatility.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$32.45
Market Cap
12.60B
PE Ratio
-3.54
EPS
-9.2737
Volume (Avg. Vol.)
9.13M
Day's Range
$31.52 - $32.80
52-Week Range
$29.25 - $170.47
Dividend & Yield
N/A (N/A)
MRNA Stock Predictions, Articles, and MODERNA News
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late.
3 Biotech Stocks to Buy in Case of Another Pandemic
These are three of the best biotech stocks to keep an eye on as the industry helps governments prepare for the next pandemic.
3 Pharma Stocks That Could Make Your Grandchildren Rich
Investors might want to consider the top pharma stocks in the current environment as they are beating most others.
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell.
3 Biotech Stocks to Sell in July Before They Crash & Burn
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late
3 Biotech Stocks Turning DNA Dreams Into Dollars
Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.
3 Nasdaq Stocks to Dump as They Near Peak Performance
Moderna, Constellation Energy and CrowdStrike are three Nasdaq stocks to sell, each offering unique exit points in a peaking market.
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
MRNA stock has climbed more than 20% in just the past five trading sessions. What's behind Moderna's recent rally?
MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024
MRNA stock results show that Moderna beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
